13 November 2020

This consultation closed on Friday 18 December 2020.

The Department of Health through the Office of Drug Control (ODC) is conducting a review of medicinal cannabis related permits granted under the Narcotics Drugs Act 1967 (the Act), including the structure and design, and relevant administrative processes.

In particular, this review considers ways to simplify permit arrangements. It also proposes implementing periodic reporting and compliance monitoring to maintain appropriate regulatory outcomes under the Medicinal Cannabis Scheme (the Scheme).

In conducting this review, the ODC therefore aims to:

  • simplify the level of detail in the permits, particularly for cultivation and production
  • allow for greater flexibility in business decision-making
  • improve the ODC’s efficiency, and
  • improve industry understanding of regulatory obligations and compliance requirements.

The ODC invites you to review the Medicinal Cannabis Permit Reform Consultation Paper and make a submission through our consultation hub.